CASI Pharmaceuticals, Inc. (CASIF)
OTC: CASIF · CIK 0001962738 · United States
Every official CASI Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CASIF filings
CASI Pharmaceuticals, Inc. documents
- CASI Pharmaceuticals, Inc. 10-K 2026CASIF 10-K 2026: annual report for fiscal 2026
- CASI Pharmaceuticals, Inc. 10-K 2025CASIF 10-K 2025: annual report for fiscal 2025
- CASI Pharmaceuticals, Inc. 10-K 2024CASIF 10-K 2024: annual report for fiscal 2024
- CASI Pharmaceuticals, Inc. 10-K 2023CASIF 10-K 2023: annual report for fiscal 2023
- CASI Pharmaceuticals, Inc. 10-K 2022CASIF 10-K 2022: annual report for fiscal 2022
- CASI Pharmaceuticals, Inc. 10-Q 2026CASIF 10-Q 2026: quarterly report for fiscal 2026
- CASI Pharmaceuticals, Inc. 10-Q 2025CASIF 10-Q 2025: quarterly report for fiscal 2025
- CASI Pharmaceuticals, Inc. 10-Q 2024CASIF 10-Q 2024: quarterly report for fiscal 2024
- CASI Pharmaceuticals, Inc. 10-Q 2023CASIF 10-Q 2023: quarterly report for fiscal 2023
- CASI Pharmaceuticals, Inc. 10-Q 2022CASIF 10-Q 2022: quarterly report for fiscal 2022
- CASI Pharmaceuticals, Inc. 8-K 2026CASIF 8-K 2026: current report for fiscal 2026
- CASI Pharmaceuticals, Inc. 8-K 2025CASIF 8-K 2025: current report for fiscal 2025
- CASI Pharmaceuticals, Inc. 8-K 2024CASIF 8-K 2024: current report for fiscal 2024
- CASI Pharmaceuticals, Inc. 8-K 2023CASIF 8-K 2023: current report for fiscal 2023
- CASI Pharmaceuticals, Inc. 8-K 2022CASIF 8-K 2022: current report for fiscal 2022
- CASI Pharmaceuticals, Inc. DEF 14A 2026CASIF DEF 14A 2026: proxy statement for fiscal 2026
- CASI Pharmaceuticals, Inc. DEF 14A 2025CASIF DEF 14A 2025: proxy statement for fiscal 2025
- CASI Pharmaceuticals, Inc. DEF 14A 2024CASIF DEF 14A 2024: proxy statement for fiscal 2024
- CASI Pharmaceuticals, Inc. DEF 14A 2023CASIF DEF 14A 2023: proxy statement for fiscal 2023
- CASI Pharmaceuticals, Inc. DEF 14A 2022CASIF DEF 14A 2022: proxy statement for fiscal 2022
- CASI Pharmaceuticals, Inc. Form 4 2026CASIF Form 4 2026: insider trading filing for fiscal 2026
- CASI Pharmaceuticals, Inc. Form 4 2025CASIF Form 4 2025: insider trading filing for fiscal 2025
- CASI Pharmaceuticals, Inc. Form 4 2024CASIF Form 4 2024: insider trading filing for fiscal 2024
- CASI Pharmaceuticals, Inc. Form 4 2023CASIF Form 4 2023: insider trading filing for fiscal 2023
- CASI Pharmaceuticals, Inc. Form 4 2022CASIF Form 4 2022: insider trading filing for fiscal 2022
- CASI Pharmaceuticals, Inc. S-1 2026CASIF S-1 2026: registration statement for fiscal 2026
- CASI Pharmaceuticals, Inc. S-1 2025CASIF S-1 2025: registration statement for fiscal 2025
- CASI Pharmaceuticals, Inc. S-1 2024CASIF S-1 2024: registration statement for fiscal 2024
- CASI Pharmaceuticals, Inc. S-1 2023CASIF S-1 2023: registration statement for fiscal 2023
- CASI Pharmaceuticals, Inc. S-1 2022CASIF S-1 2022: registration statement for fiscal 2022
- CASI Pharmaceuticals, Inc. 13F 2026CASIF 13F 2026: institutional holdings for fiscal 2026
- CASI Pharmaceuticals, Inc. 13F 2025CASIF 13F 2025: institutional holdings for fiscal 2025
- CASI Pharmaceuticals, Inc. 13F 2024CASIF 13F 2024: institutional holdings for fiscal 2024
- CASI Pharmaceuticals, Inc. 13F 2023CASIF 13F 2023: institutional holdings for fiscal 2023
- CASI Pharmaceuticals, Inc. 13F 2022CASIF 13F 2022: institutional holdings for fiscal 2022
More companies